Review
One year in review 2015: Sjögren’s syndrome
N. Luciano1, V. Valentini2, A. Calabrò3, E. Elefante4, A. Vitale5, C. Baldini6, E. Bartoloni7
- Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
- Department of Rheumatology, University of Perugia, Perugia, Italy.
- Department of Rheumatology, University of Florence, Florence, Italy.
- Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
- Department of Rheumatology, Policlinico Le Scotte, University of Siena, Siena, Italy.
- Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
- Department of Rheumatology, University of Perugia, Perugia, Italy.
CER8468
2015 Vol.33, N°2
PI 0259, PF 0271
Review
Free to view
(click on article PDF icon to read the article)
PMID: 25896475 [PubMed]
Received: 19/03/2015
Accepted : 23/03/2015
In Press: 10/04/2015
Published: 10/04/2015
Abstract
Primary Sjögren’s syndrome (pSS) is a chronic autoimmune disease mainly characterised by the inflammation of exocrine glands; however, a broad spectrum of systemic manifestations may characterise the disease. Recently, pSS has been the object of considerable immunologic and clinical research which has led to significant advances in the diagnosis, prognostic assessment and management of the disease. Herewith, we provide a critical digest of the recent literature on this topic.
